Moderna, Inc. (MRNA) earnings: date, estimates, results and stock reactions
Next earnings: Q4 FY2026 on 2027-02-12 (expected, time not announced). EPS estimate -2.08, revenue estimate 529.7M.
Over the last 12 reports the stock moved 9.5% on average (either way), rising 7 times and falling 5. EPS beat estimates 12 of 12 times; revenue 10 of 12. Close before the report date to the first close after it (two trading sessions, covering before-the-open and after-the-close reports).
| Quarter | Reported | EPS | EPS estimate | EPS surprise | Revenue | Revenue estimate | Stock move |
|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 2026-11-06 | 0.38 | -1.10 | +134.5% | 1.31B | 890.3M | +11.4% |
| Q2 FY2026 | 2026-07-31 | -1.97 | -2.03 | +3.0% | 145.0M | 102.9M | -4.8% |
| Q1 FY2026 | 2026-05-01 | -3.40 | -4.45 | +23.6% | 389.0M | 236.4M | +3.0% |
| Q4 FY2025 | 2026-02-13 | -2.11 | -2.54 | +16.9% | 678.0M | 635.2M | +9.5% |
| Q3 FY2025 | 2025-11-06 | -0.51 | -1.87 | +72.7% | 1.02B | 920.9M | +4.2% |
| Q2 FY2025 | 2025-08-01 | -2.13 | -2.99 | +28.8% | 142.0M | 893.3M | -6.5% |
| Q1 FY2025 | 2025-05-01 | -2.52 | -2.92 | +13.7% | 107.0M | 116.7M | -3.3% |
| Q4 FY2024 | 2025-02-14 | -2.50 | -2.68 | +6.7% | 956.0M | 942.8M | +12.0% |